loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about AM20061880, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    AM20061880

    APIs // Active Pharmaceutical Ingredients

    PRICE INFORMATION

    ANALYTICAL SOLUTION(s)

    PharmaCompass

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    2D Structure
    1. Also known as: 2364-75-2, 2-ethyl-6-methylpyridin-3-ol, Emoxipine, Emoxypine, 2-ethyl-6-methyl-3-hydroxypyridine, Epigid
    Molecular Formula
    C8H11NO
    Molecular Weight
    137.18  g/mol
    InChI Key
    JPGDYIGSCHWQCC-UHFFFAOYSA-N
    FDA UNII
    V247P5H4E1
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    2-ethyl-6-methylpyridin-3-ol
    2.1.2 InChI
    InChI=1S/C8H11NO/c1-3-7-8(10)5-4-6(2)9-7/h4-5,10H,3H2,1-2H3
    2.1.3 InChI Key
    JPGDYIGSCHWQCC-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CCC1=C(C=CC(=N1)C)O
    2.2 Other Identifiers
    2.2.1 UNII
    V247P5H4E1
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 2-ethyl-6-methyl-3-hydroxypyridine

    2. 2-ethyl-6-methyl-3-oxypyridine

    3. 6-methyl-2-ethyl-3-hydroxypyridine

    4. 6-methyl-2-ethyl-3-hydroxypyridine Hydrochloride

    5. 6-methyl-2-ethyl-3-hydroxypyridine Monohydrochloride

    6. Emoxipin

    7. Emoxipine

    8. Emoxypin

    9. Emoxypine

    10. Epigid

    11. Hydroxypyridine-6

    2.3.2 Depositor-Supplied Synonyms

    1. 2364-75-2

    2. 2-ethyl-6-methylpyridin-3-ol

    3. Emoxipine

    4. Emoxypine

    5. 2-ethyl-6-methyl-3-hydroxypyridine

    6. Epigid

    7. Emoxipin

    8. 2-ethyl-6-methyl-3-pyridinol

    9. 3-pyridinol, 2-ethyl-6-methyl-

    10. Epygid

    11. 6-methyl-2-ethyl-3-hydroxypyridine

    12. V247p5h4e1

    13. Mfcd00462409

    14. Emoxypin

    15. 2-ethyl-6-methyl-3-oxypyridine

    16. Brn 0115913

    17. Unii-v247p5h4e1

    18. Methylethylpiridinol

    19. Cbdive_006685

    20. 4-21-00-00559 (beilstein Handbook Reference)

    21. Schembl195347

    22. Chembl3338326

    23. Zinc36605

    24. Dtxsid40178313

    25. Hms1673l03

    26. Act00131

    27. Albb-019184

    28. Bcp13392

    29. Methylethylpiridinol [who-dd]

    30. Stk363100

    31. Akos000511507

    32. Cs-w002620

    33. Ps-4106

    34. Ncgc00342201-01

    35. Sy021192

    36. Db-002446

    37. Am20061880

    38. E0833

    39. Ft-0612254

    40. Ab01334615-02

    41. 364e752

    42. A816823

    43. A1-48854

    44. Q-100305

    45. Q4532982

    2.4 Create Date
    2005-07-07
    3 Chemical and Physical Properties
    Molecular Weight 137.18 g/mol
    Molecular Formula C8H11NO
    XLogP31.7
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count2
    Rotatable Bond Count1
    Exact Mass137.084063974 g/mol
    Monoisotopic Mass137.084063974 g/mol
    Topological Polar Surface Area33.1 Ų
    Heavy Atom Count10
    Formal Charge0
    Complexity105
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Psychotropic Drugs

    A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents). (See all compounds classified as Psychotropic Drugs.)

    Radiation-Protective Agents

    Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military. (See all compounds classified as Radiation-Protective Agents.)

    Anti-Arrhythmia Agents

    Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)

    Platelet Aggregation Inhibitors

    Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)

    Antioxidants

    Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)

    Mutagens

    Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)

    Post Enquiry
    POST ENQUIRY